Search for: "United Biotech Corporation" Results 21 - 40 of 174
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
19 May 2021, 12:30 pm by Matt Gluck
  The Biden administration will waive sanctions on the corporate entity and CEO in charge of the building of Russia’s Nord Stream 2 pipeline into Germany, reports Axios. [read post]
24 Mar 2021, 7:24 am by MaxVal
The United States emerges at the 2nd spot with 12.1% patent applications. [read post]
10 Mar 2021, 10:08 am by Rob Robinson
On the equity side, VC is widely considered as the money of invention, which may be provided by independent VC firms or corporate venture capitalists. [read post]
28 Aug 2020, 1:59 pm by Fraud Fighters
We have years of experience litigating under the False Claims Act by holding individuals and corporations accountable for fraud against the government. [read post]
24 Jul 2020, 7:07 pm
Pix Credit: HereIn a quite deliberate way, the United States has in the last several days (finally) articulated its ideological line respecting the nature and course of U.S. relations with China. [read post]
7 Apr 2020, 5:00 am by Emilia Columbo
In March, British biotech firm Mologic began collaborating with Senegalese Institut Pasteur de Dakar to produce COVID-19 test kits in a specialized facility in Senegal. [read post]
20 Mar 2020, 11:07 am by Sarah Aberg
The SEC has transitioned to a “full telework posture” in response to the outbreak of COVID-19 in the United States. [read post]
17 Mar 2020, 1:32 pm by Noble McIntyre
July 2021 FDA Recalls GENOSYL DS; Nitric Oxide Delivery System has been recalled by Vero Biotech due to software error. [read post]
28 Oct 2019, 9:07 am by John P. Feldman and Courtney E. Fisher
Cold MD, NAD Case #4653 (April 2007); Pilot Corporation of America, NAD Case #3392 (May 1997); Maximum Human Performance, LLC, NAD Case #5631 (Sept. 2013). [read post]
28 Oct 2019, 9:07 am by John P. Feldman and Courtney E. Fisher
Cold MD, NAD Case #4653 (April 2007); Pilot Corporation of America, NAD Case #3392 (May 1997); Maximum Human Performance, LLC, NAD Case #5631 (Sept. 2013). [read post]
11 Apr 2019, 6:49 am by Lindsay Griffiths
Robert Bourke, Partner, completed a Diploma in Strategic Growth (Biotech & Pharma). [read post]
18 Mar 2019, 8:49 am by Morse Barnes-Brown Pendleton
At the April 9th MassBio event Cross-Border Biotech Transactions: CFIUS and Other Risks, corporate partner John Hession will speak on the risks that early-stage biotech companies face when pursuing strategic alliances with foreign partners or investors. [read post]
3 Jul 2018, 6:25 am
Parent corporations often externalize the risk of tort liability through legally separate subsidiaries. [read post]
12 Jun 2018, 1:20 pm by Daily Record Staff
Silver Spring-based United Therapeutics Corp., a subsidiary of XVIVO Perfusion AB, announced Tuesday XVIVO’s ex-vivo lung perfusion technology will be incorporated into the laboratory of Lung Bioengineering Inc., a subsidiary of United Therapeutics’ public benefit corporation subsidiary Lung Biotechnology PBC. [read post]
26 Apr 2018, 1:00 pm by Mike Mireles
Countries including the US and the United Kingdom have mandatory obligations to report on gender balance, climate change and more, but not expressly corporate IP. [read post]
25 Apr 2018, 7:07 am by Renae Lloyd
” PixarBio Corporation is a biotech start-up formerly based in Massachusetts. [read post]
1 Feb 2018, 5:55 pm by Kevin LaCroix
We have seen securities suits filed against mid-cap, small-cap, and even micro-cap companies, particularly in fields such as life sciences, biotech and pharma. [read post]
2 Jan 2018, 5:08 pm by Kevin LaCroix
  As of December 29, 2017, the Senate has confirmed including 19 Trump administration judicial nominees, including one Associate Justice of the Supreme Court, 12 judges for the United States Courts of Appeals, and six judges for the United States District Courts. [read post]
27 Dec 2017, 10:14 am by Beth Graham
After the Federal Circuit issued its opinion, Dow filed a petition for certiorari with the Supreme Court of the United States. [read post]
20 Dec 2017, 7:36 am by Amber Walsh
., targets companies with EBITDA from $2 million to $20 million across a variety of industries, including biotech, pharmaceutical and healthcare IT. [read post]